by TractManager | Jun 30, 2020 | Health Technology Assessment
If you have a Hayes login, click here to view the full report on the Knowledge Center.
by TractManager | Jun 30, 2020 | Health Technology Assessment
Focus of the Report: This report evaluates the use of tisagenlecleucel (Kymriah) for the treatment of relapsed or refractory (r/r) B-cell acute lymphoblastic leukemia (ALL) or r/r diffuse large B-cell lymphoma (DLBCL).Technology Description: Tisagenlecleucel therapy...
by TractManager | Jun 30, 2020 | Emerging Technology Report
Givlaari is a subcutaneously administered ribonucleic acid interference (RNAi) agent that inhibits delta-aminolevulinate synthase 1 (ALAS1) synthesis, a key regulator of the heme biosynthetic pathway in the liver. Givlaari is believed to reduce ALAS1 levels, thereby...
by TractManager | Jun 24, 2020 | Health Technology Assessment
Focus of the Report: This health technology assessment focuses on the use of genicular nerve blocks (GNB) for the management of knee pain associated with osteoarthritis of the knee (KOA) or persistent pain following total knee arthroplasty (TKA). Technology...
by TractManager | Jun 23, 2020 | COVID-Articles, Health Technology Assessment
Focus of the Report: This report focuses on electronic monitoring (EM) of hand hygiene (HH) in a hospital setting. Technology Description: Electronic HH monitoring systems vary in their degree of sophistication. The simplest are straightforward counters that record...
Recent Comments